Electroacupuncture Regulates Pain Transition by Inhibiting the mGluR5-PKC? Signaling Pathway in the Dorsal Root Ganglia.

ABSTRACT: Background:Acute pain can transition to chronic pain, presenting a major clinical challenge. Electroacupuncture (EA) can partly prevent the transition from acute to chronic pain. However, little is known about the mechanisms underlying the effect of EA. This study investigated the effect of EA on pain transition and the activation of metabotropic glutamate receptor 5 (mGluR5)-protein kinase C epsilon (PKC?) signaling pathway in the dorsal root ganglia (DRG). Methods:The hyperalgesic priming model was established by the sequential intraplantar injection of carrageenan (1%, 100 ?L) and prostaglandin E2 (PGE2) into the left hind paw of rats. EA treatment (2/100 Hz, 30 min, once/day) was applied at bilateral Zusanli (ST36) and Kunlun (BL60) acupoints in rats. Von Frey filaments were used to investigate the mechanical withdrawal threshold (MWT) at different time points. The protein expression levels of mGluR5 and PKC? in the ipsilateral L4-L6 DRGs of rats were detected by Western blot. Some pharmacological experiments were performed to evaluate the relationship between mGluR5, PKC? and the MWT. It was also used to test the effects of EA on the expression levels of mGluR5 and PKC? and changes in the MWT. Results:Sequential injection of carrageenan and PGE2 significantly decreased the MWT of rats and up-regulated the expression level of mGluR5 and PKC? in the ipsilateral L4-L6 DRGs. EA can reverse the hyperalgesic priming induced by sequential injection of carrageenan/PGE and down-regulate the protein expression of mGluR5 and PKC?. Glutamate injection instead of PGE2 can mimic the hyperalgesic priming model. Pharmacological blocking of mGluR5 with specific antagonist MTEP can prevent the hyperalgesic priming and inhibit the activation of PKC? in DRGs. Furthermore, EA also produced analgesic effect on the hyperalgesic priming rats induced by carrageenan/mGluR5 injection and inhibited the high expression of PKC?. Sham EA produced none analgesic and regulatory effect. Conclusion:EA can regulate pain transition and it may relate with its inhibitory effect on the activation of mGluR5-PKC? signaling pathway in the DRGs.

SUBMITTER: Wang S 

PROVIDER: S-EPMC7311359 | biostudies-literature | 2020

REPOSITORIES: biostudies-literature